Innovation, commitment, passion, actionable data, and fast decisions are mandatory if clinical development is to keep pace with scientific knowledge in oncology and advance the right treatments to the right patients.

Your clinical development team is dedicated to meeting the significant unmet need in cancer therapies. You’re busy evaluating ever more targeted and powerful medicines, designed to stop cancer in its tracks. You’re committed to running more precise and less empirical clinical studies to maximize patient opportunity and accelerate drug development cycles. You recognize that “business as usual” in oncology drug development is simply not sustainable.

We’re right with you. We match and understand your drive and passion to advance the next generation of safer, more effective medicines to the patients who desperately need them.

We have the medical and operational expertise that you can trust to successfully engage the investigators and patients you seek to deliver your clinical studies on time and on budget. As your CRO, we work collaboratively with you, providing customized and thoughtful study or program-specific solutions.





a This is an estimate of INC Research studies from the last five years that are completed or scheduled to complete for this therapy area.